INTRODUCTION
Esophageal cancer is the eighth most common cancer globally (annually affecting 482,300 people), and its incidence is increasing. [1] [2] [3] The overall European pooled relative 1-year and 5-year survival rates are 33.4% (95% CI, 32.9% to 33.9%) and 9.8% (95% CI, 9.4% to 10.1%), respectively. 4 Centralization of esophagectomy to high-volume centers in recent years has rendered improvements in short-term complications, postoperative mortality, [5] [6] [7] and long-term survival; surgeon volume is of greater importance than hospital volume. 8, 9 The introduction of minimal-access surgery has highlighted the effect of surgeons gaining proficiency in new techniques. Typically, studies that addressed surgeon proficiency gain curves in relation to gastrointestinal cancer have focused on short-term outcomes. [10] [11] [12] Few studies have considered the changes in long-term survival as surgeons gain proficiency in laparoscopic gastrectomy, 13, 14 laparoscopic hemicolectomy, 15 and open esophagectomy. 16 These studies often describe the practice of high-volume surgeons in high-volume centers and, therefore, do not reflect the average proficiency gain curve. A study on the national proficiency gain curve in the United Kingdom in minimal-access surgery has described measurable effects upon short-term clinical outcomes after esophageal and colorectal cancer resections as surgeons gain proficiency. 17 However, to date, no study has been undertaken to assess the impact of proficiency gain on longterm mortality after cancer resection at a national level. The objective of this study was to estimate esophagectomy proficiency gain curves in terms of short-and long-term mortality in esophageal cancer in a nationwide and comprehensive cohort of patients.
PATIENTS AND METHODS

Design
The cohort used for this study has been described in detail elsewhere. 9, 18 In brief, this Swedish nationwide cohort study included 98% of all patients with esophageal cancer treated with a curative intent between 1987 and 2010, with follow-up until November 2014. From the Swedish Cancer Registry, patients with a diagnosis of esophageal cancer (150.0, 150.8, or 150.9) were identified according to the seventh edition of the International Classification of Diseases (ICD7). This registry has 98% nationwide coverage of esophageal cancer cases. 19, 20 Patients with esophageal cancer who underwent esophagectomy were identified from the Swedish Patient Registry, which has an excellent positive identification rate (99.6%) for esophageal surgery. 21 The Patient Registry also provided data about patient medical comorbidities and reoperation. 21 The comorbidities were classified according to the well-validated Charlson comorbidity score system. 22 The Swedish Causes of Death Registry was used to provide accurate data about the dates and causes of death. If the diagnosis of esophageal cancer was listed as a cause of death, then mortality was defined as disease specific. The Swedish personal identity number, assigned to each Swedish resident at birth or immigration, was used to link data between registries and in the identification of individual medical records. Medical records that contained operation notes and histopathological reports of the cohort members were retrieved from all Swedish hospitals where esophageal cancer surgery was performed. Clinical data were collected through a nationwide Swedish clinical network established in the mid-1990s. 23 Data about neoadjuvant therapy, names of the surgeons, tumor pathologic stage, histologic subtype, and lymphadenectomy were obtained from these individual patient records. The accuracy of histopathological review has been previously described; two researchers independently reviewed 100 records and demonstrated high accuracy with . 90% concordance. 24 Neoadjuvant therapy was predominantly used in more recent years and, when used, was typically a combination of chemotherapy and radiotherapy. Tumor stage was classified according to the TNM classification of the International Union Against Cancer (UICC). 25 Only open transthoracic esophageal resection was studied, and intrathoracic anastomosis was most commonly used (95%). Minimally invasive esophagectomy was performed in , 2% of cases in Sweden during the study period, which did not permit additional analysis of the proficiency gain curve. The regional ethical review board in Stockholm, Sweden, approved the study.
Outcomes
The outcomes were 30-day, 90-day, 1-year, 3-year, and 5-year allcause and disease-specific mortality. To exclude the effect of earlier mortality on the longer-term results, 90-day mortality was calculated from 30 to 90 days; 1-year mortality, from 90 days to 1-year; 3-year mortality, from 1 year to 3 years; and 5-year mortality, from 3 years to 5 years. Lymph node yield, reoperation, and resection margin status (R1/2) were examined as explanatory performance-related variables to any changes in long-term survival. R1 or R2 refer to microscopic or macroscopic presence of tumor at the resection margin, respectively.
Statistical Analysis
Follow-up of patients ended at death, emigration, or the end of the study period (November 2014), whichever occurred first. According to the unique anonymized surgeon codes within the database, the first case in each surgeon case series was assigned case one, and subsequent case numbers were assigned according to ascending date order. Risk-adjusted cumulative sum (RA-CUSUM) curves were created to define the proficiency gain curve for each mortality outcome from esophagectomy. 26 Risk prediction models for the binary outcomes were created by using logistic regression models. Potential confounding factors included in the models were age (continuous variable), sex (male or female), tumor histologic subtype (adenocarcinoma or squamous cell carcinoma), pathologic stage (stage I, II, III, or IV), use of neoadjuvant therapy (yes or no), and individual preoperative comorbidities (yes or no). The risk prediction models were used to calculate the predicted probability of each outcome in each case (the expected survival or mortality; Appendix Table A1 , online only). The curves plot the cumulative difference between the observed and expected mortality/survival (ie, CUSUM O [minus] E, on the y-axis) according to the risk-adjustment model. This difference was calculated using the CUSUM equation S i = S i21 + ( S i 2 S R ); S 0 = 0. S i is the cumulative sum, S i is the sum of events at procedure number i, and S R is the sum of expected events at procedure number i. RA-CUSUM curves were also examined for lymph node harvest, positive resection margin, and reoperation rates. On the basis of this equation, the curve increases if the observed mortality/survival exceeds the expected mortality/survival and vice versa.
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RESULTS
This study included 1,821 patients with esophageal cancer who underwent esophagectomy, and these operations were performed by a total of 139 surgeons. The median number of cases performed by the surgeons was 16, and the interquartile range was six to 46 cases; the most experienced surgeon had performed 262 cases. The median follow-up time was 491 days. The median age at surgery was 66 years, a high proportion of patients (74.7%) were men, and there was a relatively low rate of medical comorbidities (Charlson score # 1 in 79.1% of patients). There was a greater proportion of squamous cell cancers (56.2%) than adenocarcinomas (43.5%). The majority of tumors were pathologic stage II (36.4%) or III (32%), and 32.2% of patients received neoadjuvant therapy (Table 1) . Among this cohort, 1,272 patients (69.9%) had no cancer in the resection margin (R0), whereas 281 patients (15.4%) had cancer in the margin (R1/R2); 268 patients (14.7%) had missing margin data.
Proficiency Gain Curve Analysis
Short-term mortality. The 30-day and 90-day measures were short-term mortality data (Fig 1) . The incidences of 30-day and 90-day all-cause mortality for the cohort were 5.3% and 6.4%, respectively (Table 2 ). There were change-points in the proficiency gain curves at 15 cases and 22 cases, respectively, at which point the 30-day all-cause mortality decreased from 7.9% to 3.1% (P , .001; Fig 1A) and the 90-day all-cause mortality decreased from 7.3% to 5.2% (P = .079; Fig 1B) .
The incidences of 30-day and 90-day disease-specific mortality were 4.7% and 5.7%, respectively ( Table 2 ). The RA-CUSUM analysis for 30-day disease-specific mortality showed a changepoint at 15 cases, with a reduction from 7.3% to 2.5% (P , .001; Fig 1C) . The RA-CUSUM analysis for 90-day disease-specific mortality showed a significant change-point at 18 cases, and the reduction in 90-day disease-specific mortality decreased from 7.1% to 4.3% (P = .017; Fig 1D) .
Long-term mortality. The 1-, 3-and 5-year measures were long-term mortality data (Figs 2 and 3) . RA-CUSUM analysis of 1-year all-cause mortality showed a significant change-point at 53 cases, with a reduction from 34.9% to 27.7% (P = .011; Fig 2A) . A similar significant change-point was seen for 3-year all-cause mortality at 35 cases, with a reduction from 47.4% to 41.5% (P = .049; Fig 2B) . The RA-CUSUM analysis of 5-year all-cause mortality showed a significant change-point at 59 cases, with a reduction from 31.4% to 19.1% (P = .006; Fig 2C) .
RA-CUSUM analysis of 1-year disease-specific mortality showed a significant change-point at 53 cases, with a reduction from 31.8% to 24.7% (P = .01; Fig 3A) . Similarly, a change-point was seen for 3-year disease-specific mortality at 38 cases, with a reduction from 39.4% to 32.8% (P = .034; Fig 3B) . There was no apparent proficiency gain curve seen with 5-year disease-specific mortality ( Table 2 ; Fig 3C) .
Lymph Node Harvest, Resection Margin Status, and Reoperation Incidence
There was a marked increase in lymph node harvest, although it was not possible to define an exact change point because of the smooth nature of the curve (Fig 4A) . The RA-CUSUM analysis for R1/2 resection margin status showed a significant change-point at 17 cases, with a reduction from 20.9% to 15.2% (P = .004; Fig 4B) . RA-CUSUM analysis for reoperation showed a significant changepoint at 55 cases, with a reduction from 12.6% to 5% (P , .001; Fig 4C) .
DISCUSSION
This study indicates that resection of esophageal cancer has a proficiency gain curve with a measurable evolution in both shortand long-term mortality. The change-points in proficiency gain curve were earlier for short-term mortality (30-and 90-day mortality), which ranged from 15 to 22 cases, than the later 16 and a national study for minimally invasive esophagectomy in England. 17 There was a 5% reduction in 30-day mortality observed during the proficiency gain curve, which represents a non-negligible degree of patient harm as surgeons gain operative experience. Importantly, the proficiency gain curve for long-term mortality was longer. The initial focus of independent surgeon practice is likely to be short-term outcome and, in particular, the 30-day mortality. When early mortality has been reduced to an acceptable level and when the surgeon gains the technical confidence in performing the procedure, surgeons then can refine their techniques and improve the quality of the resection, which will result in better long-term survival.
There are several potential mechanisms that might contribute to the findings about the learning curve in relation to long-term survival. Although a higher lymph node yield with more experience might be one such mechanism, a recent study that was based on the same cohort as the present study showed that lymph node harvest was not an independent predictor of survival. 18 15   20   1  9  17  25  33  41  49  57  65  73  81  89  97  105  113  121  129  137  145  153  161  169  177  185  193  201  209  217  225  233  241  249  257 33  41  49  57  65  73  81  89  97  105  113  121  129  137  145  153  161  169  177  185  193  201  209  217  225  233  241  249 257 265 study might be a marker of improved oncologic surgical quality with proficiency gain. The finding that cancer involvement in the resection margin was overrepresented among surgeons in the beginning of an esophagectomy career might well contribute to the higher longer-term mortality rates, because margin involvement is a prognostic factor. 27 Finally, reductions in reoperation incidence parallel findings from a study that was based on the present database, which suggests that reoperation affects long-term survival after esophagectomy. 28 Gaining experience at the expense of patient safety or longterm survival is unacceptable, and every effort must be made to overcome the proficiency gain curve for both short-and longterm mortality results. This study showed proficiency gain in an established operation. Open esophagectomy is not a newly 1  10  19  28  37  46  55  64  73  82  91  100  109  118  127  136  145  154  163  172  181  190  199  208  217  226  235  244 253 262 1  10  19  28  37  46  55  64  73  82  91  100  109  118  127  136  145  154  163  172  181  190  199  208  217  226  235  244 253 262 www.jco.org introduced procedure; a proficiency gain curve has been traditionally observed during the dissemination of a technique, and minimal-access surgery is the typical example. 17 Nevertheless, open esophagectomy is a technically demanding procedure in which there is much to learn and optimize before proficiency can be achieved. To shorten the proficiency gain curve and to minimize avoidable harm to patients, we believe in two main strategies. The first is to base surgical training on structured programs that have a competency-based assessment before embarking on independent practice. 29,30 Such a strategy can replace the current training system on the basis of the number of procedures, the years of training, and the subjective opinions of trainers. Second, this competency-based training curriculum should be followed by a mentorship and continual technical proficiency scheme to support specialists during the initial phase of independent practice. A good example of such a structured training program was observed with the National 1  11  21  31  41  51  61  71  81  91  101  111  121  131  141  151  161  171  181  191  201  211  221  231  241  251 22  29  36  43  50  57  64  71  78  85  92  99  106  113  120  127  134  141  148  155  162  169  176  183  190  197  204  211  218  225  232  239  246  253 0   1  12  23  34  45  56  67  78  89  100  111  122  133  144  155  166  177  188  199  210  221  232  243  254 Training Program for Laparoscopic Colorectal Surgery in England. This program was a government initiative that facilitated the training of surgeons in a structured, competency-based program that shortened the proficiency gain curve and reduced patient harm during the process of surgical learning. [29] [30] [31] Methodological advantages of the current study include the population-based design with complete and unbiased inclusion of patients who had undergone esophagectomy for esophageal cancer in Sweden since 1987. Moreover, the clinical data collection combined with data available in the well-maintained registers allowed us to perform this analysis and to adjust for several potential confounding factors. Furthermore, the Swedish system with nationwide and complete population registers made it possible to observe all patients, without loss to follow-up. Finally, the large sample size improved the statistical power and counteracted chance errors.
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There are also limitations associated with retrospective observational studies such as this. Typically, national database studies are limited by the quality of data entry; however, the data set used for this study has high accuracy in the correct identification of patients who underwent esophagectomy for cancer and has a strong correlation with pathology, including tumor stage. Moreover, the medical records were retrieved and reviewed, which made it possible to have detailed clinical data, including the surgeon name as a variable required for this study. Additional unmeasured surgical factors may have improved the oncologic quality and long-term survival. Although the study period began in 1987 and, therefore, represents one of the oldest existing national data sets for esophagectomy, it is conceivable that a minority of surgeons may have begun operating before 1987; thus, the early part of their proficiency gain curve may not have been captured. The study period is rather long; therefore, it is conceivable that improvements in other areas over time, including clinical staging that led to better patient selection for surgical intervention or improvements in neoadjuvant therapy regimens and enhanced recovery protocols, may have contributed to the improvement in short-and longterm outcomes during the surgical proficiency gain. However, it is important to note that case 1 was taken by surgeons at the start of their practice and that the practices showed temporal variations throughout the study period; despite the presumed improvements seen in other areas, there was a quantifiable proficiency gain curve in terms of short-and long-term survival. Finally, although risk adjustment in CUSUM analysis did include pathologic stage, histologic subtype, use of neoadjuvant therapy, and patient demographics, including comorbidities, there may have been additional unknown confounding factors that may have contributed to the observed changes in survival.
In conclusion, to our knowledge, this is the first study to evaluate the change in long-term mortality at a national level as the surgeon gains proficiency in performing open esophagectomy for cancer, and shows that the length of the proficiency gain curve was shorter for short-term than for long-term mortality. The adverse impact of proficiency gains upon patient outcomes may be negated with competency-based training programs before surgeons embark on independent practice that are followed by a mentoring and a continual proficiency scheme during the initial practice as specialists.
AUTHORS' DISCLOSURES OF POTENTIAL CONFLICTS OF INTEREST
Disclosures provided by the authors are available with this article at www.jco.org. 
AUTHOR CONTRIBUTIONS
Conception
